Immediately after switching the page, it will work with CSR.
Please reload your browser to see how it works.
Paper suggesting mood alteration: https://www.cell.com/cell/abstract/S0092-8674(25)00278-8
I researched more about it and looks like some of the deficiency in the vitamins in the study are correlated with higher IL-17 levels.
Carnitine: Seems to have some effect in decreasing IL-17?
Vitamin D: Highly impacts IL-17 (https://pmc.ncbi.nlm.nih.gov/articles/PMC4609465/)
COQ10: Decreased plasma levels of IL-17 (https://www.clinicalnutritionespen.com/article/S2405-4577(22...)
Folic Acid: Reduces IL-17 (https://pmc.ncbi.nlm.nih.gov/articles/PMC8839991/)
Lutein: I didn't find any study that seems to study the effect on IL-17
Citrulline: No relevant studies
This is the study I'm referring to: https://www.nature.com/articles/s41398-023-02696-9
I think we're getting closer to find some blood level correlations, so we can fix them!
I can say for a fact when I take CoQ10, I feel my energy levels going up so it really has some effect.
Related: "N-acetylcysteine as a new prominent approach for treating psychiatric disorders" https://doi.org/10.1111/bph.15456 section "2.3 Regulation of inflammatory mediators".
N-acetylcysteine (NAC) is considered safe and is sold as a diet supplement in USA and many other countries. If you suffer from anxious feelings, 1200mg/day NAC may reduce them a lot.
All those possible targets need to be verified by actual treatments. Treating the increased diabetes type 2 risk in depressed people is still advantagous but won't help the depression much. It's like changing tires on a broken car. Pushing is easier, but won't run by itself.
At the same time, bimekizumab, one of the bleeding-edge psoriasis and psoriatic arthritis treatments, suppresses production of IL-17A and IL-17F (methotrexate does that, too, albeit to a much smaller degree). As a result, people receiving IL-17 suppressors become happier over the course of years, and not only due to months-long remission - I had a chance to see this in one of the experimental treatment programs.